• 4 results in Exploration of Neuroprotective Therapy
    Sort by
    Latest
    Open Access
    Review
    Neuroprotective agents in acute ischemic stroke
    Acute ischemic stroke (AIS) is the leading cause of disability and one of the top causes of mortality worldwide. The current standard of care is reperfusion therapy including intravenous thrombolysi [...] Read more.
    Grace YY Chia ... Benjamin YQ Tan
    Published: February 28, 2023 Explor Neuroprot Ther. 2023;3:47–70
    DOI: https://doi.org/10.37349/ent.2023.00037
    This article belongs to the special issue The Future of Biomarkers in CNS Diseases
    View:1665
    Download:76
    Open Access
    Review
    Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
    Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting 1% of the population above sixty years. It is caused by an interaction between genetic and envi [...] Read more.
    Khaled Radad ... Wolf-Dieter Rausch
    Published: February 27, 2023 Explor Neuroprot Ther. 2023;3:24–46
    DOI: https://doi.org/10.37349/ent.2023.00036
    This article belongs to the special issue Parkinsons Disease: Principal Targets and Interventional Mechanisms
    View:918
    Download:42
    Times Cited: 0
    Open Access
    Review
    Can chronic therapeutic drug use by the elderly affect Alzheimer’s disease risk and rate of progression?
    There is no approved drug capable of halting the progression of the most prevalent neurodegenerative disorders, namely Alzheimer's disease (AD) and Parkinson's disease (PD).  [...] Read more.
    Rafael Franco, Joan Serrano-Marín
    Published: February 27, 2023 Explor Neuroprot Ther 2023;3:8–23
    DOI: https://doi.org/10.37349/ent.2023.00035
    This article belongs to the special issue The Urgent Need for New Hypotheses to Develop Effective Therapeutic Tools Against Alzheimers Disease
    Open Access
    Perspective
    Machine learning as a new tool in neurological disease prevention, diagnosis, and treatment
    More than 600 different neurological diseases affect the human population. Some of these are genetic and can emerge even before birth, and some are caused by defects, infections, trauma, degeneratio [...] Read more.
    Cinzia Volonté
    Published: February 21, 2023 Explor Neuroprot Ther. 2023;3:1–7
    DOI: https://doi.org/10.37349/ent.2023.00034
    View:905
    Download:33
    Times Cited: 0